These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3400097)

  • 1. Metabolic evidence for the involvement of enzymatic bioactivation in the cataractogenicity of acetaminophen in genetically susceptible (C57BL/6) and resistant (DBA/2) murine strains.
    Lubek BM; Basu PK; Wells PG
    Toxicol Appl Pharmacol; 1988 Jul; 94(3):487-95. PubMed ID: 3400097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies on the in vivo cataractogenicity of acetaminophen in mice and rabbits.
    Lubek BM; Avaria M; Basu PK; Wells PG
    Fundam Appl Toxicol; 1988 May; 10(4):596-606. PubMed ID: 3396787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic modulation of acetaminophen bioactivation and hepatotoxicity by pretreatment with the interferon inducer polyinosinic-polycytidylic acid.
    Kalabis GM; Wells PG
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1408-19. PubMed ID: 2262910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo murine studies on the biochemical mechanism of acetaminophen cataractogenicity.
    Wells PG; Wilson B; Winn LM; Lubek BM
    Can J Physiol Pharmacol; 1995 Aug; 73(8):1123-9. PubMed ID: 8564879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo murine studies on the biochemical mechanism of naphthalene cataractogenesis.
    Wells PG; Wilson B; Lubek BM
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):466-73. PubMed ID: 2749733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation and toxicity of acetaminophen in congenic RHA rats with or without a hereditary deficiency in bilirubin UDP-glucuronosyltransferase.
    de Morais SM; Chow SY; Wells PG
    Toxicol Appl Pharmacol; 1992 Nov; 117(1):81-7. PubMed ID: 1440617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency in bilirubin UDP-glucuronyl transferase as a genetic determinant of acetaminophen toxicity.
    de Morais SM; Wells PG
    J Pharmacol Exp Ther; 1988 Oct; 247(1):323-31. PubMed ID: 3139868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome.
    de Morais SM; Uetrecht JP; Wells PG
    Gastroenterology; 1992 Feb; 102(2):577-86. PubMed ID: 1732127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of acetaminophen- and naphthalene-induced cataract and glutathione loss by CySSME.
    Rathbun WB; Holleschau AM; Cohen JF; Nagasawa HT
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):923-9. PubMed ID: 8603877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diethyl ether on the bioactivation, detoxification, and hepatotoxicity of acetaminophen in vitro and in vivo.
    Wells PG; To EC
    Adv Exp Med Biol; 1986; 197():707-15. PubMed ID: 3766289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced acetaminophen toxicity in rats with bilirubin glucuronyl transferase deficiency.
    de Morais SM; Wells PG
    Hepatology; 1989 Aug; 10(2):163-7. PubMed ID: 2501210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cysteine pro-drugs on acetaminophen-induced hepatotoxicity.
    Hazelton GA; Hjelle JJ; Klaassen CD
    J Pharmacol Exp Ther; 1986 Apr; 237(1):341-9. PubMed ID: 3958971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical determination of inducibility phenotype with a monoclonal antibody to a methylcholanthrene-inducible isozyme of cytochrome P-450.
    Anderson LM; Ward JM; Park SS; Jones AB; Junker JL; Gelboin HV; Rice JM
    Cancer Res; 1987 Nov; 47(22):6079-85. PubMed ID: 3664509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical changes associated with the potentiation of acetaminophen hepatotoxicity by brief anesthesia with diethyl ether.
    To EC; Wells PG
    Biochem Pharmacol; 1986 Dec; 35(23):4139-52. PubMed ID: 3790145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of hepatic glutathione homeostasis and prevention of acetaminophen-induced cataract in mice by L-cysteine prodrugs.
    Rathbun WB; Killen CE; Holleschau AM; Nagasawa HT
    Biochem Pharmacol; 1996 May; 51(9):1111-6. PubMed ID: 8645331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetaminophen produces cataract in DBA2 mice by Ah receptor-independent induction of CYP1A2.
    Qian W; Shichi H
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):337-44. PubMed ID: 10977129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of acetaminophen and its metabolites in mouse tissues after a toxic dose.
    Fischer LJ; Green MD; Harman AW
    J Pharmacol Exp Ther; 1981 Nov; 219(2):281-6. PubMed ID: 7288620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury.
    Shayiq RM; Roberts DW; Rothstein K; Snawder JE; Benson W; Ma X; Black M
    Hepatology; 1999 Feb; 29(2):451-63. PubMed ID: 9918922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-, tissue-, and Ah genotype-dependent differences in the binding of 3-methylcholanthrene and its metabolite(s) to mouse DNA.
    Lu LJ; Harvey RG; Lee H; Baxter JR; Anderson LM
    Cancer Res; 1990 Jul; 50(14):4239-47. PubMed ID: 2364382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of acetaminophen-induced cataract by a combination of diallyl disulfide and N-acetylcysteine.
    Zhao C; Shichi H
    J Ocul Pharmacol Ther; 1998 Aug; 14(4):345-55. PubMed ID: 9715438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.